Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 23 for “"erastin"”.

  1. ESTABLISHMENT AND CHARACTERIZATION OF ERASTIN-RESISTANT TRIPLE NEGATIVE BREAST CANCER CELL MODELS

    … and expand after cellular cysteine depletion by erastin, an inhibitor of cystine transporter. This in vitro observation may substantially mimic tumor relapse in patients after targeted cysteine-addiction therapy. The three aims of this study are: 1) Develop in vitro erastin-resistant TNBC cell …

    mtu Repository record for ESTABLISHMENT AND CHARACTERIZATION OF ERASTIN-RESISTANT TRIPLE NEGATIVE BREAST CANCER CELL MODELS (opens in a new tab)

  2. Atsparumo feroptozei molekuliniai mechanizmai kasos vėžio ląstelėse /

    … with sensitivity to ferroptosis inducer erastin. With this in mind, several EMT targeting compounds were evaluated for their effects on cell sensitivity to erastin and new effective combinations of erastin and EMT-modulating compounds were discovered.

    vilnius Repository record for Atsparumo feroptozei molekuliniai mechanizmai kasos vėžio ląstelėse / (opens in a new tab)

  3. Χαρτογράφηση και Φαρμακολόγηση του Μοριακού Τοπίου Ογκογονικότητας, στον Ανθρώπινο Ουροθηλιακό Καρκίνο της Ουροδόχου Κύστης: Νέοι Στόχοι και Καινοτόμα Χημειοθεραπευτικά Σχήματα

    … Με βάση τα αποτελέσματα ξεχώρισαν, εκτός από την Erastin και άλλοι δύο χημικοί παράγοντες, οι FINO2 και RSL3, ο καθένας εκ των οποίων υποθέτουμε ότι επάγει το φαινόμενο μέσω διαφορετικού σηματοδοτικού μονοπατιού. Στη συνέχεια, μελετήθηκε η επίδραση των συγκεκριμένων φαρμάκων στην ικανότητα …

    athens Repository record for Χαρτογράφηση και Φαρμακολόγηση του Μοριακού Τοπίου Ογκογονικότητας, στον Ανθρώπινο Ουροθηλιακό Καρκίνο της Ουροδόχου Κύστης: Νέοι Στόχοι και Καινοτόμα Χημειοθεραπευτικά Σχήματα (opens in a new tab)

  4. TARGETING CYSTEINE METABOLISM TO ERADICATE TRIPLE-NEGATIVE BREAST CANCER

    … TNBC sustains resistance to multi-cycle erastin treatment, which most likely mimics tumor relapse in patients after therapy. To limit the risk of tumor recurrence and decipher the underlying mechanism, we enriched and established the erastin-resistant/recurrent TNBC cell models in-vitro. …

    mtu Repository record for TARGETING CYSTEINE METABOLISM TO ERADICATE TRIPLE-NEGATIVE BREAST CANCER (opens in a new tab)

  5. Metabolically rewiring pancreatic stromal cells in pancreatic cancer

    … different SLC7A11 inhibitors, sulfasalazine and erastin. Sulfasalazine proved ineffective at reducing orthotopic pancreatic tumour growth, indicating it cannot be repurposed as PC therapy. Excitingly, erastin showed significant anti-proliferative effects in both PC cells and CA-PSCs. In CA-PSCs, …

    unsw Repository record for Metabolically rewiring pancreatic stromal cells in pancreatic cancer (opens in a new tab)

  6. INVESTIGATING CYSTEINE DEPENDENCE IN PANCREATIC CANCER AND DETERMINING THE REGULATORY ROLE OF SELENOPROTEIN SEPP1 IN FERROPTOSIS

    … with cysteine depletion can overcome the erastin-resistance in the epithelial-type PDAC cells. In addition, we found that Sepp1 modulates the Trx system on both transcriptional and translational levels. Overall, our study suggests that pancreatic cancer exhibits differential cysteine …

    mtu Repository record for INVESTIGATING CYSTEINE DEPENDENCE IN PANCREATIC CANCER AND DETERMINING THE REGULATORY ROLE OF SELENOPROTEIN SEPP1 IN FERROPTOSIS (opens in a new tab)

  7. Dissecting the Role of Selenoprotein P and Thioredoxin Reductase in Pancreatic Cancer Metabolism

    … deprivation of cystine or blocking its uptake by erastin (a cystine transport inhibitor) triggers significant lipid peroxidation, thereby inducing ferroptosis specifically in the mesenchymal subtype of PDAC, but not in the epithelial subtype. This study aims to elucidate the roles of Selenoprotein …

    mtu Repository record for Dissecting the Role of Selenoprotein P and Thioredoxin Reductase in Pancreatic Cancer Metabolism (opens in a new tab)

  8. UNDERSTANDING THE MECHANISM OF FERROPTOSIS SUSCEPTIBILITY VARIATION IN COLORECTAL CANCER

    … cell viability in response to the treatment of erastin, a known chemical inducer of cell death primarily through ferroptosis. To determine ferroptotic cell death, we measured the levels of lipid peroxidation using the molecular probe BODIPY 581/591 C11, and various inhibitors to distinguish …

    uky-thes Repository record for UNDERSTANDING THE MECHANISM OF FERROPTOSIS SUSCEPTIBILITY VARIATION IN COLORECTAL CANCER (opens in a new tab)

  9. Charakterisierung der suppressiven Funktion von Vitamin K1 im Verlauf der Ferroptose

    … sowie Primärzellen mit den Ferroptoseinduktoren Erastin und RSL3 zeigten, dass Vitamin K1 die Ferroptose effektiv inhibiert, während sie durch Phenprocoumon verstärkt wird. Dies betrifft nicht nur den Zelltod, sondern auch die Radikalbildung selbst. Mithilfe des murinen renalen bilateralen …

    cau-kiel Repository record for Charakterisierung der suppressiven Funktion von Vitamin K1 im Verlauf der Ferroptose (opens in a new tab)

  10. Modulation of Ferroportin in Oral Cancer

    … the efficacy of indirect ferroptosis inducers, erastin and Sulfasalazine, as well as employed an experimental iron overloading drug Feraheme. We observed a level of sensitivity with the low ferroportin expressing cells.

    vcu Repository record for Modulation of Ferroportin in Oral Cancer (opens in a new tab)

  11. CUTANEOUS MELANOMA DRIVES METABOLIC CHANGES IN THE AGED BONE MARROW IMMUNE MICROENVIRONMENT

    … cells undergoing ferroptosis. Imidazole ketone erastin and aging can affect intracellular ferrous iron levels, lipid peroxidation levels, and immune cell populations. Ultimately, melanoma induces an age-specific metabolic response systemically in the BM niche, which renders these immune cells …

    jhu Repository record for CUTANEOUS MELANOMA DRIVES METABOLIC CHANGES IN THE AGED BONE MARROW IMMUNE MICROENVIRONMENT (opens in a new tab)

  12. Molecular Mechanisms of TAZ-regulating Ferroptosis in Cancer Cells and tRNA Fragment in Erythrocytes

    … oxidase(s). The canonical ferroptosis inducer, erastin, is a small molecule which triggers oxidative stress by inhibiting the cystine-glutamate transporter (xCT) and thus reduces intracellular cysteine level and glutathione biosynthesis. Recent studies indicate ferroptosis may have therapeutic …

    duke Repository record for Molecular Mechanisms of TAZ-regulating Ferroptosis in Cancer Cells and tRNA Fragment in Erythrocytes (opens in a new tab)

  13. Targeting ferroptosis pathway to overcome erlotinib resistance

    … erlotinib-resistant cells were more sensitive to erastin- and radiation-induced ferroptosis. We also found that erlotinib-resistant cells exhibited significantly higher lipid peroxidation and lipid droplet accumulation, which were further enhanced following ferroptosis induction. To validate our …

    oxford Restricted access

  14. ELUCIDATING THE IMPACT OF PYRUVATE KINASE ON CYSTINE METABOLISM AND FERROPTOSIS IN PANCREATIC CANCER

    … and cystine starvation with imidazole ketone erastin (IKE) in vitro. Preliminary investigations in vivo show strong potential for this drug combination as a novel and effective therapy for PDAC.

    msu Repository record for ELUCIDATING THE IMPACT OF PYRUVATE KINASE ON CYSTINE METABOLISM AND FERROPTOSIS IN PANCREATIC CANCER (opens in a new tab)

  15. Ferroptosis as a mechanism of skeletal muscle dysfunction in peripheral artery disease.

    … ischemia (CLI) patients were analyzed alongside erastin-treated myotubes. Ferroptosis was active in CLI but not IC muscle, driven by coordinated changes in iron metabolism, lipid handling, and autophagy, specifically upregulation of HMOX1, ACSL4, ELAVL1, and BECN1. TFRC was surprisingly …

    baylor Repository record for Ferroptosis as a mechanism of skeletal muscle dysfunction in peripheral artery disease. (opens in a new tab)

  16. Large-Scale Analysis of Protein-Gas and Protein-Metal Interactions using Mass Spectrometry-Based Proteomic Methods

    … study of Fe- and Zn-mediated sensitization to erastin-induced ferroptotic cell death. Our approach enabled differential protein expression and protein folding stability measurements to be made on RCC4 cells exposed to excess iron and zinc along with the ferroptosis-inducing molecule erastin. Of …

    duke Repository record for Large-Scale Analysis of Protein-Gas and Protein-Metal Interactions using Mass Spectrometry-Based Proteomic Methods (opens in a new tab)

  17. Μοριακή ανάλυση του μεταγραφώματος των ριβοσωμάτων κατά την ερυθροποίηση και -ομική προσέγγιση για τη φαρμακολογική αξιοποίηση στις ριβοσωμοπάθειες

    … was further tested through treatment with erastin, a well-known ferroptosis inducer, which led to a modest increase in erythroid markers; however, its pronounced cytotoxic stress appeared to outweigh any differentiating potential. Collectively, this work characterizes STEAP3 as an enzyme …

    greece Repository record for Μοριακή ανάλυση του μεταγραφώματος των ριβοσωμάτων κατά την ερυθροποίηση και -ομική προσέγγιση για τη φαρμακολογική αξιοποίηση στις ριβοσωμοπάθειες (opens in a new tab)

  18. Elucidating the molecular mechanisms underlying androgen-regulated lipid metabolism in prostate cancer

    … elicited resistance to the ferroptosis inducers Erastin and ML210. Our study has revealed a novel mechanism by which AR regulates lipid metabolism in PCa cells. Importantly, the critical role of ACSM1 and ACSM3 as key regulators of growth and protectors against ferroptosis emphasises their …

    adelaide Repository record for Elucidating the molecular mechanisms underlying androgen-regulated lipid metabolism in prostate cancer (opens in a new tab)

  19. The crosstalk of ferroptosis and autophagy regulated by MAFF

    … cells following induction of ferroptosis using erastin or sulfasalazine. RCC4 renal cell carcinoma cells were also included in the study to determine whether MAFF regulation was cancer-type specific. Lastly, siRNA screening was performed by Celigo to identify target genes of MAFF in the …

    oxford Restricted access

  20. Stress hormone-induced dysregulation of the brain selenoproteome and selenium homeostasis

    … in cultures treated with and without CORT and erastin, a ferroptotic death inducer, and changes in electrophysiological properties of our cultures. We discovered that changes in selenoproteins, which require both glucocorticoid and mineralocorticoid receptor signaling, happen in a cell-type …

    hawaii Repository record for Stress hormone-induced dysregulation of the brain selenoproteome and selenium homeostasis (opens in a new tab)

Page 1 of 2